Vanessa Almendro, Elliot Berger, Benjamin McCloud, and Turna Ray go behind the headlines to discuss 2024’s biggest trends in the pharmaceutical industry, as well as the unforeseen outcomes that took ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

The system is Hapman’s first major product launch since 2008, following a year of intensive R&D that builds upon the company’s eight decades of tubular drag conveyor expertise. Rather than relying on ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Posdinemab is the second tau-directed investigational therapy by J&J that has received fast track designation from FDA this year for Alzheimer’s disease. The final guidance is a revision of a policy ...

Brian Feth, Jonathan Grinstein, PhD, Beth Willers, and Laks Pernenkil go behind the headlines to discuss major news announcements made during the JP Morgan Healthcare Conference, a wave of new ...